phase 1_2_completion
saveWuhan YZY Biopharma Co Ltd — M-701 (Phase I/II Trial Completion)
community read0 votes
Therapy area: Oncology, Respiratory. Indication: Malignant Pleural Effusion, Non-Small Cell Lung Cancer
Therapy area: Oncology, Respiratory. Indication: Malignant Pleural Effusion, Non-Small Cell Lung Cancer
comments(0)
5-min edit window · permanent after that